Diana Hausman - Jan 14, 2022 Form 3 Insider Report for Immuneering Corp (IMRX)

Role
Director
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Diana F. Hausman
Stock symbol
IMRX
Transactions as of
Jan 14, 2022
Transactions value $
$0
Form type
3
Date filed
1/18/2022, 07:19 AM
Next filing
Jun 23, 2022

No securities are beneficially owned.